1.
American Institute of Ultrasound in Medicine. AIUM practice guideline for the performance of a breast ultrasound examination. J Ultrasound Med. 2009;28:105–9.
3.
Hilton SV, Leopold GR, Olson LK, Willson SA. Real-time breast sonography: application in 300 consecutive patients. AJR Am J Roentgenol. 1986;147:479–86.
PubMed
4.
Hong AS, Rosen EL, Soo MS, Baker JA, et al. BI-RADS for sonography: positive and negative predictive values of sonographic features. AJR Am J Roentgenol. 2005;184:1260–5.
PubMed
5.
Mendelson EB, Baum JK, Berg WA, Merritt CB, Rubin E. Breast imaging reporting and data system BIRADS: ultrasound. In: D’Orsi CJ, Mendelson EB, Ikeda DM, et al., editors. Breast imaging reporting and data system. 1st ed. Reston: American College of Radiology; 2003.
6.
Soo MS, Rosen EL, Baker JA, Vo TT, Boyd BA. Negative predictive value of sonography with mammography in patients with palpable breast lesions. AJR Am J Roentgenol. 2001;177:1167–70.
PubMed
7.
Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004;233:830–49.
PubMed
8.
Mendelson EB. Problem-solving ultrasound. Radiol Clin North Am. 2004;42:909–18.
PubMed
9.
Parker SH, Jobe WE, Dennis MA, et al. US-guided automated large-core breast biopsy. Radiology. 1993;187:507–11.
PubMed
10.
Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299:2151–63.
PubMedPubMedCentral
11.
Gordon PB. Ultrasound for breast cancer screening and staging. Radiol Clin North Am. 2002;40:431–41.
PubMed
12.
Alvarez S, Anorbe E, Alcorta P, Lopez F, Alonso I, Cortes J. Role of sonography in the diagnosis of axillary lymph node metastases in breast cancer: a systematic review. AJR Am J Roentgenol. 2006;186:1342–8.
PubMed
13.
Esen G, Gurses B, Yilmaz MH, et al. Gray scale and power Doppler US in the preoperative evaluation of axillary metastases in breast cancer patients with no palpable lymph nodes. Eur Radiol. 2005;15:1215–23.
PubMed
14.
D’Orsi C, Mendelson E, Bassett L, et al. American College Of Radiology, ACR appropriateness criteria 2000: work-up of nonpalpable breast masses. Radiology. 2000;215(S):965–72.
PubMed
15.
Evans 3rd WP, Mendelson E, Bassett L, et al. Appropriate imaging work-up of palpable breast masses. American College of Radiology. ACR appropriateness criteria. Radiology. 2000;215(Suppl):961–4.
PubMed
16.
Leung JW, Sickles E. Multiple bilateral masses detected on screening mammography: assessment of need for recall imaging. AJR Am J Roentgenol. 2000;175(1):23–9.
PubMed
17.
Berg WA, Zhang Z, Cormack JB, Mendelson EB. Multiple Bilateral Circumscribed Masses at Screening Breast US: Consider Annual Follow-up. Radiology. 2013;268(3):673–83.
PubMedPubMedCentral
18.
Sickles EA. Detection and diagnosis of breast cancer with mammography. Perspect Radiol. 1988;1:36–65.
19.
Shetty MK, Shah YP, Sharman RS. Prospective evaluation of the value of combined mammographic and sonographic assessment in patients with palpable abnormalities of the breast. J Ultrasound Med. 2003;22(3):263–8.
PubMed
20.
Stavros AT, Thickman D, Rapp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonography to distinguish between benign and malignant lesions. Radiology. 1995;196:123–34.
PubMed
21.
Berg WA, Sechtin AG, Marques H, Zhang Z. Cystic breast masses and the ACRIN 6666 experience. Radiol Clin North Am. 2010;48(5):931–87.
PubMedPubMedCentral
22.
Rinaldi P, Ierardi C, Costantini M, Magno S, Giuliani M, Belli P, Bonomo L. Cystic breast lesions: sonographic findings and clinical management. J Ultrasound Med. 2010;29(11):1617–26.
PubMed
23.
Daly CP, Bailey JE, Klein KA, Helvie MA. Complicated breast cysts on sonography: is aspiration necessary to exclude malignancy? Acad Radiol. 2008;15(5):610–7.
PubMed
24.
Huff JG. The sonographic findings and differing clinical implications of simple, complicated, and complex breast cysts. J Natl Compr Canc Netw. 2009;7(10):1101–4.
PubMed
25.
Hines N, Slanetz PJ, Eisneberg R. Cystic masses of the breast. AJR Am J Roentgenol. 2010;194:W122–33.
PubMed
26.
Sklair-Levy M, Muradali D, Kulkarni S. Linear transducer harmonic imaging: improved characterization of breast cysts compared to conventional sonography. AJR Am J Roentgenol. 2001;176:6–7.
27.
Merritt C, Piccoli C, Forsberg F, Wilkes A, Cavanaugh B, Lee S. Real-time spatial compound imaging of the breast: clinical evaluation of masses. Radiology. 2000;217:491–2.
28.
Shetty MK, Watson Jr AB. Sonographically occult screen detected breast masses: a retrospective analysis of cases undergoing biopsy. Clin Imaging. 2008;32(1):28–31.
PubMed
29.
Shetty MK, Watson AW. Mondor’s disease of the breast: sonographic and mammographic findings. AJR Am J Roentgenol. 2001;177(4):893–6.
PubMed
30.
Adrada B, Yun W, Yang W. Hyperechoic lesions of the breast: radiologic-histopathologic correlation. AJR Am J Roentgenol. 2013;200:W518–30.
PubMed
31.
Georgian-Smith D, Taylor KJW, Madjar H, et al. Sonography of palpable breast cancer. J Clin Ultrasound. 2000;28:211–6.
PubMed
32.
Mainiero MB, Goldkamp A, Lazarus E. Characterization of breast masses with sonography can biopsy of some solid masses be deferred? J Ultrasound Med. 2005;24(2):161–7.
PubMed
33.
Rahbar G, Sie AC, Hansen GC, et al. Benign versus malignant solid breast masses: US differentiation. Radiology. 1999;213:889–94.
PubMed
34.
D’Orsi CJ, Mendelson EB, Ikeda DM, et al. Breast imaging reporting and data system: ACR BI-RADS – breast imaging atlas. Reston: American College of Radiology; 2003.
35.
Shetty MK, Watson AB. Sonographic evaluation of focal asymmetric density of the breast. Ultrasound Q. 2002;18(2):115–21.
PubMed
36.
Sickles EA. The spectrum of breast asymmetries: imaging features, work-up, management. Radiol Clin North Am. 2007;45(5):765–71.
PubMed
37.
Youk JH, Kim EK, Ko KH, Kim MJ. Asymmetric mammographic findings based on the fourth edition of BI-RADS: types, evaluation, and management. Radiographics. 2009;29(1):e33.
PubMed
38.
Samardar P, de Paredes ES, Grimes MM, Wilson JD. Focal asymmetric densities seen at mammography: US and pathologic correlation. Radiographics. 2002;22(1):19–33.
PubMed
39.
Leung JWT, Sickles EA. Developing asymmetry identified on mammography: correlation with imaging outcome and pathologic findings. AJR Am J Roentgenol. 2007;188(3):667–75.
PubMed
40.
Donegan WL. Evaluation of a palpable breast mass. N Engl J Med. 1992;327:937–42.
PubMed
41.
Rosner D, Blair D. What ultrasonography can tell in breast masses that mammography and physical examination cannot. J Surg Oncol. 1985;28:308–13.
PubMed
42.
Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999;130:651–7.
PubMed
43.
Perdue P, Page D, Nellestein M, Salem C, Galbo C, Ghosh B. Early detection of breast carcinoma: a comparison of palpable and nonpalpable lesions. Surgery. 1992;111:656–9.
PubMed
44.
Kopans DB. Palpable abnormalities and breast imaging. In: Breast imaging. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 1998. p. 747–59.
45.
Coveney EC, Geraghty JG, O’Laoide R, Hourihane JB, O’Higgins NJ. Reasons underlying negative mammography in patients with palpable breast cancer. Clin Radiol. 1994;49:123–5.
PubMed
46.
Dennis MA, Parker SH, Klaus AJ, Stavros AT, Kaske TI, Clark SB. Breast biopsy avoidance: the value of normal mammograms and normal sonograms in the setting of a palpable lump. Radiology. 2001;219:186–91.
PubMed
47.
Weinstein SP, Conant EF, Orel SG, Zuckerman JA, Czeriecki B, Lawton TJ. Retrospective review of palpable breast lesion: negative mammography and sonography. J Womens Imaging. 2000;2:15–8.
48.
Moy L, Slantez PJ, Moore R, et al. Specificity of mammography and US in the evaluation of a palpable abnormality. Radiology. 2002;225:176–81.
PubMed
49.
Shetty MK, Shah YP. Prospective evaluation of the value of negative sonographic and mammographic findings in patients with palpable abnormalities of the breast. J Ultrasound Med. 2002;21(11):1211–6; quiz 1217–9.
PubMed
50.
Moss HA, Britton PD, Flower CDR, Freeman AH, Lomas DJ, Warren RML. How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population? Clin Radiol. 1999;54:676–82.
PubMed
51.
Kaiser JS, Helvie MA, Blacklaw RL, Roubidoux MA. Palpable breast thickening: role of mammography and US in cancer detection. Radiology. 2002;223:839–44.
PubMed
52.
Sickles EA. Periodic mammographic follow-up of probably benign lesions: results in 3,184 consecutive cases. Radiology. 1991;179(2):463–8.
PubMed
53.
Vizcaíno I, Gadea L, Andreo L, Salas D, Ruiz-Perales F, Cuevas D, Herranz C, Bueno F. Short-term follow-up results in 795 nonpalpable probably benign lesions detected at screening mammography. Radiology. 2001;219(2):475–83.
PubMed
54.
Dawson JS. Wilson AR Short-term recall for “probably benign” mammographic lesions detected in a three yearly screening programme. Clin Radiol. 1994;49(6):391–5.
PubMed
55.
Kaplan SS, Collado-Mesa F, Ekens J, Thurber M. Palpable solid breast masses with probably benign sonographic features: can biopsy be avoided? Breast J. 2013;19(2):212–4.
PubMed
56.
Park YM, Kim EK, Lee JH, Ryu JH, Han SS, Choi SJ, Lee SJ, Yoon HK. Palpable breast masses with probably benign morphology at sonography: can biopsy be deferred? Acta Radiol. 2008;49(10):1104–11.
PubMed
57.
Graf O, Helbich TH, Fuchsjaeger MH, Hopf G, Morgun M, Graf C, Mallek R, Sickles EA. Follow-up of palpable circumscribed noncalcified solid breast masses at mammography and US: can biopsy be averted? Radiology. 2004;233(3):850–6.
PubMed
58.
Graf O, Helbich TH, Hopf G, Graf C, Sickles EA. Probably benign breast masses at US: is follow-up an acceptable alternative to biopsy? Radiology. 2007;244(1):87–93.
PubMed
59.
Giess CS, Smeglin LZ, Meyer JE, Ritner JA, Birdwell RL. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management. J Ultrasound Med. 2012;31(12):1943–9.
PubMed
60.
Harvey JA, Nicholson BT, LoRusso AP, Cohen MA, Bovbireg VE. Short-term follow-up of palpable breast lesions with benign imaging features: evaluation of 375 lesions in 320 Women. AJR Am J Roentgenol. 2009;193:1723–30.
PubMed
61.
Bent CK, Bassett LW, D’Orsi CJ, Sayre JW. The positive predictive value of BI-RADS microcalcification descriptors and final assessment categories. AJR Am J Roentgenol. 2010;194:1378–83.
PubMed
62.
Morrow M. The evaluation of common breast problems. Am Fam Physician. 2000;61(8):2371–8.
PubMed
63.
Howard MB, Battaglia T, Prout M, Freund K. The effect of imaging on the clinical management of breast pain. J Gen Intern Med. 2012;27(7):817–24.
PubMedPubMedCentral
64.
Duijm LEM, Guit GL, Hendriks JHCL, Zaat JOM, Mali WPTM. Value of breast imaging in women with painful breasts: observational follow up study. BMJ. 1998;317:1492–5.
PubMedPubMedCentral
65.
Tumyan L, Hoyt AC, Bassett LW. Negative predictive value of sonography and mammography in patients with focal breast pain. Breast J. 2005;11(5):333–7.
PubMed
66.
Morrogh M, Park A, Elkin EB, King TA. Lessons learned from 416 cases of nipple discharge of the breast. Am J Surg. 2010;200(1):73–80.
PubMed
67.
Kamali S, Bender O, Kamali GH, Aydin MT, Karatepe O, Yuney E. Breast diagnostic and therapeutic value of ductoscopy in nipple discharge and intraductal proliferations compared with standard methods. Cancer. 2014;21(2):154–61.
68.
Okazaki A, Hirata K, Okazaki M, Svane G, Azavedo E. Nipple discharge disorders: current diagnostic management and the role of fiber-ductoscopy. Eur Radiol. 1999;9(4):583–90.
PubMed
69.
Zervoudis S, Iatrakis G, Economides P, Polyzos D, Navrozoglou I. Nipple discharge screening. Womens Health (Lond Engl). 2010;6(1):135–51.
70.
Yamamoto D, Shoji T, Kawanishi H, Nakagawa H, Haijima H, Gondo H, et al. A utility of ductography and fiberoptic ductoscopy for patients with nipple discharge. Breast Cancer Res Treat. 2001;70:103–8.
PubMed
71.
Ueng S, Mezzetti T, Tavassoli FA. Papillary neoplasms of the breast. Arch Pathol Lab Med. 2009;133:893–907.
PubMed
72.
Grunwald S, Heyer H, Paepke S, Schwesinger G, Schimming A, Hahn M, et al. Diagnostic value of ductoscopy in the diagnosis of nipple discharge and intraductal proliferations in comparison to standard methods. Onkologie. 2007;30:243–8.
PubMed
73.
Gioffre FMA, Manganero T, Pollicino A, Paola S, Biagio M. Surgical approach to nipple discharge: a ten-year experience. J Surg Oncol. 1999;71:235–8.
74.
Maxwell AJ. Ultrasound-guided vacuum-assisted excision of breast papillomas: review of 6-years experience. Clin Radiol. 2009;64:801–6.
PubMed
75.
Louie LD, Crowe JP, Dawson AE, et al. Identification of breast cancer in patients with pathologic nipple discharge: does ductoscopy predict malignancy? Am J Surg. 2006;192:530–3.
PubMed
76.
Van Zee KJ, Ortega Perez G, Minnard E, Cohen MA. Preoperative galactography increases the diagnostic yield of major duct excision for nipple discharge. Cancer. 1998;82:1874–80.
PubMed
77.
Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr. 2010;2010(41):134–8.
PubMed
78.
Schnitt SJ, Silen W, Sadowsky NL, et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 1988;318:898–903.
PubMed
79.
Tabar L, Vitak B, Chen HH, et al. The Swedish Two-County Trial twenty years later. Updated mortality results and new insights from long-term follow-up. Radiol Clin North Am. 2000;38:625–51.
PubMed
80.
Stomper PC, Connolly JL, Meyer JE, et al. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic pathologic correlation. Radiology. 1989;172:235–41.
PubMed
81.
Mun HS, Shin HJ, Kim HH, Cha JH, Kim H. Screening-detected calcified and non-calcified ductal carcinoma in situ: Differences in the imaging and histopathological features. Clin Radiol. 2013;68(1):e27–35.
PubMed
82.
Gwak YJ, Kim HJ, Kwak JY, Lee SK, et al. Ultrasonographic detection and characterization of asymptomatic ductal carcinoma in situ with histopathologic correlation. Acta Radiol. 2011;52(4):364–71.
PubMed
83.
Nagashima T, Hashimoto H, Oshida K, et al. Ultrasound demonstration of mammographically detected microcalcifications in patients with ductal carcinoma in situ of the breast. Breast Cancer. 2005;12(3):216–20.
PubMed
84.
Moon WK, Myung JS, Lee YJ, Park IA, Noh DY, Im JG. US of ductal carcinoma in situ. Radiographics. 2002;22(2):269–80.
PubMed
85.
Yang WT, Tse GMK. Sonographic, mammographic, and histopathologic correlation of symptomatic ductal carcinoma in situ. AJR Am J Roentgenol. 2004;182:101–10.
PubMed
86.
Shin HJ, Kim HH, Kim SM, Kwon GY, Gong G, Cho OK. Screening-detected and symptomatic ductal carcinoma in situ: differences in the sonographic and pathologic features. AJR Am J Roentgenol. 2008;190(2):516–25.
PubMed
87.
Gufler H, Buitrago-Téllez CH, Madjar H. Ultrasound demonstration of mammographically detected microcalcifications. Acta Radiol. 2000;41(3):217–21.
PubMed
88.
Cheung YC, Wan YL, Chen SC. Sonographic evaluation of mammographically detected microcalcifications without a mass prior to stereotactic core needle biopsy. J Clin Ultrasound. 2002;30(6):323–31.
PubMed
89.
Kang SS, Ko EY, Han B, et al. Breast US in patients who had microcalcifications with low concern of malignancy on screening mammography. Eur J Radiol. 2008;67(2):285–91.
PubMed
90.
Kim EY, Ko EY, Han BK, Shin JH. Sonography of axillary masses: what should be considered other than the lymph nodes? J Ultrasound Med. 2009;28(7):923–39.
PubMed
91.
Walsh R, Kornguth PJ, Soo MS, Bentley R, DeLong DM. Axillary lymph nodes: mammographic, pathologic, and clinical correlation. AJR Am J Roentgenol. 1997;168(1):33–8.
PubMed
92.
Ampil F, Caldito G, Henderson B, Li B, Kim RH, Burton G, Chu Q. Carcinoma of the axillary tail of Spence: a case series. Anticancer Res. 2012;32(9):4057–9.
PubMed
93.
Song SE, Seo BK, Choi JW, Son GS, Cho KR, Kim BH. The sonographic “coffee bean” sign helps distinguish an axillary neurofibroma from a lymphadenopathy. J Clin Ultrasound. 2014;42(1):33–7.
PubMed
94.
Sohn YM, Kim SY, Kim EK. Sonographic appearance of a schwannoma mimicking an axillary lymphadenopathy. J Clin Ultrasound. 2011;39(8):477–9.
PubMed
95.
Shetty MK, Carpenter WS. Sonographic evaluation of isolated abnormal axillary lymph nodes identified on mammograms. J Ultrasound Med. 2004;23(1):63–71.
PubMed
96.
Given-Wilson RM, Murray ME. The clinical importance of axillary lymphadenopathy detected on screening mammography. Clin Radiol. 1997;52:458–61.
PubMed
97.
Bergvist L, Frodis E, Hedborg-Mellander C, Hansen J. Management of accidentally found pathological lymph nodes on routine screening mammography. Eur J Surg Oncol. 1996;22:250–3.
98.
Srivastava A, Hughes LE, Woodcock JP, Laidler P. Vascularity in cutaneous melanoma detected by Doppler sonography and histology: correlation with tumour behavior. Br J Cancer. 1989;59(1):89–91.
PubMedPubMedCentral
99.
Schroeder RJ, Bostanjoglo M, Rademaker J, Maeurer J, Felix R. Role of power Doppler techniques and ultrasound contrast enhancement in the differential diagnosis of focal breast lesions. Eur Radiol. 2003;13(1):68–79.
PubMed
100.
Giuseppetti GM, Baldassarre S, Marconi E. Color Doppler sonography. Eur J Radiol. 1998;27 Suppl 2:S254–8.
PubMed
101.
Kook SH, Park HW, Lee YR, Lee YU, Pae WK, Park YL. Evaluation of solid breast lesions with power Doppler sonography. J Clin Ultrasound. 1999;27(5):231–7.
PubMed
102.
Milz P, Lienemann A, Kessler M, Reiser M. Evaluation of breast lesions by power Doppler sonography. Eur Radiol. 2001;11(4):547–54.
PubMed
103.
Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler US. Radiology. 1997;203(1):164–8.
PubMed
104.
Barr RG. Sonographic breast elastography: a primer. J Ultrasound Med. 2012;31(5):773–83.
PubMed
105.
Barr RG, Destounis S, Lackey II LB, Svensson WE, Balleyguier C, Smith C. Evaluation of breast lesions using ultrasound elasticity imaging: a multicenter trial. J Ultrasound Med. 2012;31:281–7.
PubMed
106.
Kim MJ, Kim JY, Yoon JH, Youk JH, Moon HJ, Son EJ, Kwak JY, Kim EK. How to find an isoechoic lesion with breast US. Radiographics. 2011;31(3):663–76.
PubMed
107.
Zhao QL, Ruan LT, Zhang H, Yin YM, Duan SX. Diagnosis of solid breast lesions by elastography 5-point score and strain ratio method. Eur J Radiol. 2012;81(11):3245–9.
PubMed
108.
Thitaikumar A, Ophir J. Effect of lesion boundary conditions on axial strain elastograms: a parametric study. Ultrasound Med Biol. 2007;33(9):1463–7.
PubMedPubMedCentral
109.
Itoh A, Ueno E, Tohno E, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239(2):341–50.
PubMed
110.
Yoon JH, Jung HK, Lee JT, Ko KH. Shear-wave elastography in the diagnosis of solid breast masses: what leads to false-negative or false-positive results? Eur Radiol. 2013;23(9):2432–40.
PubMed
111.
Youk JH, Gweon HM, Son EJ, Han KH, Kim JA. Diagnostic value of commercially available shear-wave elastography for breast cancers: integration into BI-RADS classification with subcategories of category 4. Eur Radiol. 2013;23(10):2695–704.
PubMed
112.
Cho N, Jang M, Lyou CY, Park JS, Choi HY, Moon WK. Distinguishing benign from malignant masses at breast US: combined US elastography and color doppler US – influence on radiologist accuracy. Radiology. 2012;262(1):80–90.
PubMed
113.
Dempsey PJ. New ultrasound-based imaging technologies are claimed to avoid unnecessary breast biopsies, but what is an “unnecessary” image-guided needle biopsy of the breast? J Clin Ultrasound. 2010;38(3):111–2.
PubMed